Gliflozine verbessern nach Myokardinfarkt nicht die Prognose

MMW Fortschr Med. 2024 Oct;166(17):27. doi: 10.1007/s15006-024-4366-5.

[Article in German]

Author

Robert H G Schwinger¹

Affiliation

¹ Klinikum Weiden/ Med. Klinik II, Kliniken Nordoberpfalz AG, Söllnerstr. 16, 92637, Weiden in der Oberpfalz, Deutschland.

PMID: 39390170
DOI: 10.1007/s15006-024-4366-5

No abstract available

Publication types

Review
Comment

MeSH terms

Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / diagnosis
Diabetes Mellitus, Type 2 / drug therapy
Humans
Myocardial Infarction* / diagnosis
Myocardial Infarction* / mortality
Prognosis
Sodium-Glucose Transporter 2 Inhibitors / adverse effects
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use

Substances

Sodium-Glucose Transporter 2 Inhibitors